Immunoclin (Immunoclin) Dividend Payout Ratio : 0.00 (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Dividend Payout Ratio?

Immunoclin's dividend payout ratio for the months ended in Oct. 2014 was 0.00.

The historical rank and industry rank for Immunoclin's Dividend Payout Ratio or its related term are showing as below:

IMCL's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-25), the Dividend Yield % of Immunoclin is 0.00%.

Immunoclin's Dividends per Share for the months ended in Oct. 2014 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Immunoclin Dividend Payout Ratio Historical Data

The historical data trend for Immunoclin's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Dividend Payout Ratio Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Dividend Payout Ratio

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Dividend Payout Ratio	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Immunoclin's Dividend Payout Ratio

For the Biotechnology subindustry, Immunoclin's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Immunoclin's Dividend Payout Ratio falls into.

Immunoclin Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Immunoclin's Dividend Payout Ratio for the fiscal year that ended in Jan. 2014 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jan. 2014 )	/	EPS without NRI (A: Jan. 2014 )
	=	0	/	-1.21
	=	N/A

Immunoclin's Dividend Payout Ratio for the quarter that ended in Oct. 2014 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Oct. 2014 )	/	EPS without NRI (Q: Oct. 2014 )
	=	0	/	-0.22
	=	N/A

Immunoclin (GREY:IMCL) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Immunoclin Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Immunoclin's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines